How Much Weight Can I Expect to Lose on Wegovy?

Last reviewed: June 30, 2026

Last updated: June 30, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Weight loss results on semaglutide depend on multiple factors beyond the medication itself. Clinical trials show average weight reductions of 10–22% of baseline body weight, but your personal outcome will reflect your unique genetic makeup, starting point, and treatment adherence. PlexusDx compounds pharmaceutical-grade semaglutide and uses genetic insights to customize your dose escalation and therapy protocol.

What Do Clinical Trials Show About Semaglutide Weight Loss?

The STEP trials, which studied semaglutide dosing and efficacy, documented an average weight loss of 15.3% of body weight in participants receiving the highest maintenance dose over 68 weeks. Participants starting at lower doses and escalating gradually showed consistent progression, with most achieving meaningful results between weeks 12 and 24. These results occurred in combination with lifestyle modification, including diet and physical activity guidance.

Weight loss typically follows a predictable pattern: initial results emerge around weeks 4–8, accelerate through weeks 12–20, and stabilize by week 16–24 at higher maintenance doses. The trajectory varies individually based on insulin sensitivity, metabolic rate, and adherence to the dose schedule. PlexusDx monitors your progress and adjusts your protocol if needed to keep you on track.

How Individual Genetics Influence Your Semaglutide Results

Your genetic blueprint affects how your body responds to GLP-1 agonists like semaglutide. Specific variants in the GLP1R gene (such as rs6923761), FTO gene (rs9939609), and MC4R gene (rs17782313) influence appetite signaling, metabolic rate, and how aggressively your body responds to treatment. People with certain genetic profiles may see faster initial weight loss, while others experience more gradual but sustained results.

PlexusDx offers the Precision Peptide Genetic Test, which maps 14 metabolic pathways and 49 peptide variants to reveal your personal response profile. This test identifies whether your weight-loss potential aligns better with semaglutide, tirzepatide, or a dual-compound approach—before committing to a full treatment plan. Understanding your genetics removes guesswork and accelerates your path to meaningful results.

Dose Escalation and Weight Loss Progression

Semaglutide dosing starts low and increases gradually to minimize side effects and allow your body to adapt. Most protocols begin at 0.25 mg weekly, escalating every 4 weeks until reaching a therapeutic maintenance dose. Weight loss tends to accelerate as your dose climbs, but your monthly price stays the same—PlexusDx compounds all doses at a flat rate of $149/month and up, ensuring your cost doesn't rise as your therapeutic needs do.

The timeline to reach full dose typically spans 16–20 weeks. Participants often report noticeable appetite suppression by week 2–3, but measurable weight loss becomes consistent after 4–6 weeks at each dose level. Patience with the escalation schedule is critical; rushing the dose progression increases nausea risk without speeding results. PlexusDx provides dose schedules tailored to your tolerance and genetic profile to optimize both safety and efficacy.

Realistic Weight Loss Expectations and Long-Term Outcomes

A realistic expectation is 1–2 pounds per week during the active weight-loss phase, typically continuing for 12–24 months depending on your starting weight and dose. Participants who began with a BMI over 35 often experience larger absolute losses (20–50+ pounds), while those with a BMI near 30 may see 15–25 pounds of reduction. Weight loss plateaus when calorie deficit stabilizes; maintaining your result requires sustained medication use and lifestyle habits.

After reaching your goal weight, many people transition to a lower maintenance dose to prevent regain. Weight regain of 30–50% of lost weight commonly occurs after stopping semaglutide, which is why long-term treatment is often recommended. PlexusDx supports you throughout your journey with access to licensed 503A compounding pharmacies in all 50 states, no insurance required, and no membership fees—making it easier to stay consistent and retain your hard-won progress.

How Your Genetics Influence GLP-1 Response

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.

Frequently Asked Questions

How much weight should I lose in my first month on semaglutide?

Most people lose little to no weight in the first month (weeks 0–4) while starting at the lowest dose (0.25 mg). Noticeable appetite suppression typically begins within 2–3 weeks, but measurable weight loss usually starts between weeks 4–8 as your body adapts and the medication reaches therapeutic levels. PlexusDx monitors your early response and adjusts your protocol if needed.

Is 15% weight loss typical, or can I lose more?

Clinical trials report an average of 15% weight loss over 68 weeks, but individual results range from 10–22% depending on genetics, baseline BMI, and lifestyle factors. People with higher starting weights and stronger genetic responses to GLP-1 agonists often exceed 15% loss. The Precision Peptide Genetic Test helps predict your personal potential by analyzing variants in GLP1R, FTO, and MC4R genes.

Will my cost increase as my semaglutide dose goes up?

No. PlexusDx charges a flat rate of $149/month for compounded semaglutide injections across all dose levels—your dose may need to go up, your price won't. This pricing model removes barriers to reaching your therapeutic dose without worrying about escalating costs. PlexusDx serves all 50 states, accepts HSA/FSA, and requires no insurance or membership.

What happens to my weight if I stop taking semaglutide?

Clinical evidence shows that weight regain occurs in most people after stopping semaglutide, with approximately 30–50% of lost weight returning within 1–2 years. This is why ongoing medication is typically recommended for long-term success. PlexusDx makes it affordable and accessible to continue treatment by offering consistent monthly pricing and convenient delivery to your home.

How does genetic testing improve my semaglutide results?

PlexusDx Precision Peptide Genetic Test analyzes 150+ genetic insights across 14 metabolic pathways to reveal whether semaglutide, tirzepatide, or a dual-compound approach aligns with your biology. For example, certain GLP1R and GIPR variants predict stronger or weaker responses to specific medications, allowing PlexusDx to recommend the protocol most likely to deliver your best results for $99 as an add-on after your first month.

Related Reading

• Wegovy For Losing Weight
• Wegovy For Weight Loss 2
• Wegovy Weight Loss Pills
• Wegovy Vs Zepbound Weight Loss

Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.